Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. (Q40823709)

24 September 2017

title

Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I. (English)

1 reference

24 September 2017

Wallace PK

1

1 reference

24 September 2017

Tsang KY

2

1 reference

24 September 2017

Goldstein J

3

1 reference

24 September 2017

Correale P

4

1 reference

24 September 2017

Jarry TM

5

1 reference

24 September 2017

Schlom J

6

1 reference

24 September 2017

Guyre PM

7

1 reference

24 September 2017

Ernstoff MS

8

1 reference

24 September 2017

Fanger MW

9

1 reference

24 September 2017

publication date

1 February 2001

1 reference

Journal of Immunological Methods

24 September 2017

published in

1 reference

24 September 2017

volume

248

1 reference

24 September 2017

issue

1-2

1 reference

24 September 2017

page(s)

183-194

1 reference

TAP1-independent loading of class I molecules by exogenous viral proteins

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Processing and presentation of intact hen egg-white lysozyme by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

7 January 2021

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Tumor-infiltrating lymphocytes from nonrenal urological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fc gamma receptor-mediated phagocytosis requires tyrosine kinase activity and is ligand independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

MHC class I presentation of live and heat-inactivated Sendai virus antigen in T2Kb cells depends on an intracellular compartment with endosomal characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Interleukin-2 transfected prostate cancer cells generate a local antitumor effect in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Antigen presentation for T cell interleukin-2 secretion is a late acquisition of neonatal B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

A new foreign policy: MHC class I molecules monitor the outside world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Demonstration of a rational strategy for human prostate cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Adoptive immunotherapy using lymphokine-activated killer cells and recombinant interleukin-2 in preventing and treating spontaneous pulmonary metastases of syngeneic Dunning rat prostate tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Interleukin-6: a candidate mediator of human prostate cancer morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Humanized mAb H22 binds the human high affinity Fc receptor for IgG (FcgammaRI), blocks phagocytosis, and modulates receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Fc gamma RI blockade and modulation for immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Human tumor antigens recognized by T lymphocytes: implications for cancer therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900351-3

10.1016/S0022-1759(00)00351-3

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference